Remdesivir infusion
Southern Health and Social Care TrustcontractFind a Tender ↗Ref ocds-h6vhtk-068d6dProcurement Act 2023active
Estimated value
—
Awarded value
£300k
Awarded 28 Apr 2026
Suppliers
1
Lots
1
1 awarded
Published
29 Apr 2026
Description
The intended contract is for the supply of Remdesivir infusion for the treatment of viral disease for a period of 3 years
Scope
- Reference
- L-DAC_0426/135
- Commercial tool
- Standalone contract
Submission & procedure
- Procedure
- Direct award
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£300k
Award date
28 Apr 2026
Contract start
13 May 2026
Contract end
13 May 2029
Awarded to
GS
CH 02543818
Awarded suppliers· 1 supplier
Awarded 28 Apr 2026 · Contract period 13 May 2026 — 13 May 2029
Award value
£300k
Other contracts from Southern Health and Social Care Trust
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to GILEAD SCIENCES LTD· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Grant Funding - Gilead Science under Grant 25759 | contract | — | 23 Jun 2026 |
| HIV Medicines | contract | — | 07 May 2026 |
| Biktarvy | contract | — | 28 Apr 2026 |
| Biktarvy | contract | — | 28 Apr 2026 |
| NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives | contract | — | 26 Feb 2026 |
| Antiretroviral Drugs | contract | — | 06 May 2025 |
| NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024 | contract | £48.2m | 28 Nov 2024 |
| NHS National Framework for Transition products commencing 1 October 2024 | contract | £1.4m | 17 Oct 2024 |
| NP49124 Hepatitis C Medicines | contract | — | 21 Mar 2024 |
| NHS London Branded Medicines - Tranche B - September 2023 | contract | £6.4m | 11 Aug 2023 |